A study by Shiryaev and colleagues suggests PCSK2 is involved in an inflammatory proteolytic pathway in which matrix metalloproteinases (MMP-25 in particular) are activated causing demyelination in MS (Shiryaev et al., 2009). The gene discussed is MMP25; the disease is myeloid sarcoma.